Gain expert insight on emerging treatment approaches for patients with head and neck squamous cell carcinoma, including the safety and tolerability of emerging treatments, survivorship care, and much more. This podcast is presented by leading experts, Barbara Burtness, MD, Professor of Medicine at Yale School of Medicine and Smilow Cancer Hospital, and Lynsey Teulings, NP, Nurse Practitioner at Yale New Haven Health. Listen now!

In this interview, Allison Imahiyerobo, APN, discusses strategies to optimize the treatment of immune thrombocytopenia (ITP).

In this interview, Allison Imahiyerobo, APN, discusses strategies to optimize the treatment of immune thrombocytopenia (ITP).

In this podcast, Dr. Steven Horwitz from Memorial Sloan Kettering Cancer Center will be discussing recent advances in the treatment of T-cell lymphoma.

If you enjoyed this podcast and want to learn more on Updates on Therapeutic Advances in T-Cell Lymphoma, visit i3Health.com/t-cell-lymphoma-enduring

In this podcast, Dr. Steven Horwitz from Memorial Sloan Kettering Cancer Center will be discussing recent advances in the treatment of T-cell lymphoma.

If you enjoyed this podcast and want to learn more on Updates on Therapeutic Advances in T-Cell Lymphoma, visit i3Health.com/t-cell-lymphoma-enduring

In this podcast, Dr. Sara Tolaney from Dana-Farber Cancer Institute will be discussing strategies to improve the management of metastatic breast cancer.

If you enjoyed this podcast and want to learn more on Optimizing Personalized Care Plans for Patients With Metastatic Breast Cancer, visit i3Health.com/metastatic-bc for free CME/NCPD.

In this podcast, Dr. Sara Tolaney from Dana-Farber Cancer Institute will be discussing strategies to improve the management of metastatic breast cancer.

If you enjoyed this podcast and want to learn more on Optimizing Personalized Care Plans for Patients With Metastatic Breast Cancer, visit i3Health.com/metastatic-bc for free CME/NCPD.

In this podcast, Dr. Kelly Brassil, PhD, RN, from The University of Texas MD Anderson Cancer Center, will be discussing patient-reported symptom data and how it affects patient survival and quality of life.

If you enjoyed this podcast, and want to learn more on Novel and Emerging Treatment Strategies for Advanced Classical Hodgkin Lymphoma with Dr. Kelly Brassil, visit https://i3health.com/ODA-HL for free CME.

To claim credit and obtain further information, including faculty disclosures, visit i3Health.com/ODA-cervical.

While the survival rate for localized cervical cancer is high, patients with metastatic disease face a poor prognosis with limited treatment options. This episode of Oncology Data Advisor will provide an update on immunotherapeutic strategies for recurrent and metastatic cervical cancer. It features perspectives from two noted experts in the field: Dr. Bradley Monk, Professor of Gynecologic Oncology at the University of Arizona College of Medicine; and Ms. Jennifer Filipi, nurse practitioner at Massachusetts General Hospital.

This activity is supported by an independent educational grant from Merck. Free CME and NCPD credit are available for this podcast.

To claim CME credit, visit https://i3health.com/oda-thyroid

While thyroid cancer is the most common endocrine cancer, prognosis and survival rates vary widely by subtype. This episode of Oncology Data Advisor will focus on advances in the management of differentiated and anaplastic thyroid cancers. It features perspectives from two noted experts in the field: Dr. Jochen Lorch, Director of the Thyroid Cancer Center at Dana-Farber Cancer Institute; and Ms. Carolyn Grande, Oncology Nurse Practitioner at Abramson Cancer Center.

This activity is supported by an educational grant from Lilly. For further information concerning Lilly grant funding, visit www.lillygrantoffice.com. Free CME and NCPD credit are available for this podcast. To claim credit and obtain further information, including faculty disclosures, visit i3Health.com/ODA-thyroid.